Endura-KT™ a Patented Formulation is a Compounded Preparation manufactured by a 503B registered Outsourcing Manufacturing Facility that is inspected by the FDA, State Board of Pharmacy and the DEA
Educational Overview for Healthcare Professionals
Endura-KT™ is a 503B-compounded anesthetic preparation containing tetracaine, lidocaine, and epinephrine, provided for licensed healthcare professionals who determine that a compounded option supports their patient-specific or procedural needs.
Endura-KT™ is a preservative-free, compounded anesthetic preparation produced by an FDA-registered 503B outsourcing facility.
Our goal is to provide clinicians with clear, responsible, and compliant educational information that supports understanding of this compounded option, including its components, handling, and potential procedural applications as determined by the healthcare provider.
What Endura-KT Offers (Educational Information Only)
- A combination of three well-established anesthetic ingredients provided in a sterile, ready-to-use format.
- A formulation prepared in accordance withFDA 503B Outsourcing Facility standards, including cGMP manufacturing.
- Availability in multiple vial sizes to support procedural flexibility across various clinical settings.
- Designed for use by licensed clinicians who determine if a compounded preparation is appropriate for their patients.
Supporting Clinician Decisions Through Education
Endura-KT is not FDA-approved; as a 503B-compounded preparation, it is intended to address clinical situations where healthcare professionals determine that available FDA-approved products may not meet specific patient or procedural needs.
Ventis Pharma provides educational resources only, and all clinical decisions—including dosing, use protocols, and patient-specific risk assessments—are made solely by the treating provider.
A Focus on Quality, Safety, and Compliance
Our 503B outsourcing partner follows:
- cGMP standards
- Routine FDA, State Board of Pharmacy and DEA inspections
- Batch-level sterility, potency, and endotoxin testing
- Documented lot release procedures
We are committed to ensuring that clinicians have access to accurate, compliant, and transparent information about the preparation they choose to use.
Intended Audience
This website is designed for licensed healthcare professionals involved in perioperative care, procedural anesthesia, surgery, dentistry, emergency medicine, and other clinical specialties.
Compliance Disclaimer
Endura-KT™ is a 503B compounded preparation and has not been evaluated or approved by the FDA. Educational content is provided solely for licensed healthcare professionals to support informed clinical decision-making.
No safety or efficacy claims are being made.
Ventis Mission Statement:
Provide a 503B-Compounded Local Anesthetic Preparation for Procedural Care—Built on Quality, Consistency, and Clinician-Centered Design.
Hospital Surgery / Perioperative Teams
Endura-KT is a sterile 503B-compounded anesthetic preparation that may be incorporated into perioperative workflows at the clinician’s discretion. Surgical teams may consider compounded anesthetic preparations in cases where FDA-approved alternatives do not meet patient-specific or procedural requirements.
Anesthesia (Anesthesiologists, CRNAs, AAs)
Endura-KT is a 503B-compounded combination of tetracaine, lidocaine, and epinephrine formulated for use by licensed anesthesia providers. It may be chosen when a clinician determines that a compounded anesthetic preparation aligns with a particular block technique, workflow, or patient presentation.
Emergency Medicine & Trauma
Emergency clinicians may use Endura-KT—a 503B-compounded anesthetic formulation—when they determine that a compounded preparation supports their approach to procedural analgesia, laceration management, or other emergent interventions requiring localized anesthesia.
Ambulatory Surgery Centers (ASC)
Endura-KT is a sterile 503B-compounded anesthetic option that ASC providers may select when they determine that a ready-to-use compounded formulation supports their procedural environment, workflow efficiency, or individualized patient needs.
Orthopedic Surgery
Orthopedic teams may consider Endura-KT—a 503B-compounded anesthetic preparation—when determining approaches to perioperative procedural anesthesia, including scenarios where clinicians believe a compounded option may meet surgical or patient-specific requirements.
OB-GYN Surgery
OB-GYN providers may incorporate Endura-KT, when appropriate, as a 503B-compounded anesthetic preparation in procedures requiring localized or adjunctive anesthesia, based on clinician judgement regarding patient needs and procedural goals.
Plastic & Reconstructive Surgery
Licensed plastic surgeons may use Endura-KT—a 503B-compounded tetracaine/lidocaine/epinephrine formulation—when determining their anesthetic approach for reconstructive or aesthetic procedures requiring localized anesthesia.
Wound Care / Limb Salvage / Chronic Ulcer Procedures
Wound care specialists may elect to use Endura-KT as a 503B-compounded anesthetic preparation when localized anesthesia is needed for debridement or procedural interventions and when clinicians determine that a compounded option supports patient-specific needs.
Orthopedic Surgery
Oncology surgical teams may choose Endura-KT, a 503B-compounded anesthetic preparation, when a clinician determines that a tailored anesthetic formulation supports the requirements of tumor-related or complex surgical interventions.
Podiatry
Podiatric surgeons may consider Endura-KT, a 503B-compounded anesthetic preparation, when determining localized anesthesia strategies for foot and ankle procedures based on patient-specific or procedural-specific needs.
Proctology / Colorectal Surgery
Colorectal and proctologic surgeons may incorporate Endura-KT—when deemed appropriate by the clinician—as a 503B-compounded anesthetic preparation to support localized anesthesia for office-based or surgical interventions.